Agensys, Inc.
Agensys, Inc., a subsidiary of Astellas Pharm
2225 Colorado Avenue
Santa Monica
California
90404
United States
Tel: 310-820-8029
Fax: 310-382-2802
Website: http://www.urogenesys.com/
Email: info@urogenesys.com
54 articles about Agensys, Inc.
-
Astellas Pharma Inc. Adds Two Key Senior Executives at Agensys, Inc.
12/1/2011
-
Seattle Genetics, Inc. and Agensys, Inc., an Affiliate of Astellas Pharma Inc., Announce Co-Development of Second Antibody-Drug Conjugate (ADC) Under Existing Collaboration
6/9/2011
-
Agensys, Inc. Announces Retirement of Donald Rice and Appointment of Sef Kurstjens as CEO and President
11/2/2010
-
Agensys, Inc., an Affiliate of Astellas Pharma Inc., and Seattle Genetics, Inc. Announce Initiation of Phase I Clinical Trial of ASG-5ME for Prostate Cancer
10/20/2010
-
Seattle Genetics, Inc. Achieves Milestone under Antibody-Drug Conjugate Collaboration with Agensys, Inc., an Affiliate of Astellas Pharma Inc.; Seattle Has Received $130 Million to date With Potential to Receive $2.7 Billion
9/2/2010
-
Seattle Genetics, Inc. Achieves Milestone under Antibody-Drug Conjugate Collaboration with Agensys, Inc., an Affiliate of Astellas Pharma Inc.
9/2/2010
-
Agensys, Inc. Announces Initiation of Phase I Clinical Trial of AGS-16M8F for Renal Cancer
9/1/2010
-
Seattle Genetics, Inc. and Agensys, Inc., an Affiliate of Astellas Pharma Inc., Announce Initiation of Phase I Clinical Trial of ASG-5ME for Pancreatic Cancer
7/20/2010
-
Seattle Genetics, Inc. andAgensys, Inc., an Affiliate of Astellas, Report ASG-5ME Preclinical Data at AACR
4/21/2010
-
Seattle Genetics, Inc. (JOBS) and Agensys, Inc., an Affiliate of Astellas Pharma Inc. (JOBS), Expand Antibody-Drug Conjugate Collaboration; Agensys Will Pay $12 Million
11/23/2009
-
Agensys, Inc. Founder, President, & CEO Dr. Donald Rice Named Ernst & Young LLP Entrepreneur Of The Year(R) 2008 Award Winner
6/26/2008
-
Japan's Astellas Pharma Inc. to Buy U.S. Agensys, Inc. for $387 Million
11/27/2007
-
Agensys, Inc. Raises $41 Million Series D Financing
7/12/2007
-
Agensys, Inc. Initiates Phase I Clinical Trial In Prostate Cancer with Monoclonal Antibody AGS-PSCA
11/1/2005